Site map

Pages

• Home
• Company
  • Board of Directors
  • Corporate Responsibility
  • Management team
• Technologies
• Products
  • Product contacts
• Pipeline
  • Pipeline chart
  • Commercial opportunity
• Investors
  • Regulatory news
  • Share price summary
  • Share price chart
  • Analyst coverage
  • Financial reports
  • Financial calendar
  • Registrars
  • AIM rule 26
  • Warning to shareholders
  • Email alerts
  • Investor contacts
  • Historic transactions
• Careers
  • Job Applicant Privacy Notice
  • Opportunities
  • Careers contacts
• Media
  • Press releases
  • Presentations
  • Webcasts & audio
  • Image library
  • Media contacts
• Contacts
  • Locations
  • Departments
  • Conferences
• Legal notice
• Data Protection and Privacy Policy
• Privacy shield policy
• Site map

Technologies

• Particle-engineered respiratory therapies
  • Direct substitutes and novel formulations
• NIOX® FeNO testing

Pipeline

• Novel LABA / LAMA formulation & novel COPD therapy formulation
• Duaklir® US
• Flixotide® / Flovent® substitute
• Seretide® substitute
• Spiriva® substitute

Locations

• UK Head Office
• US Headquarters
• Swedish Headquarters
• China Office
• German Office

Departments

• Careers Contacts
• Media Contacts
• Investor Contacts
• Product Contacts
• Medical Affairs Grants